New species, a new assay endpoint, a new image modality – we build on the same AI pipeline behind FINS, CellVision, and SpheroidVision instead of starting from scratch.
Same scoring pipeline and QC review layer as our existing apps
Trained on your data using the same AI pipeline as our existing apps
Typical turnaround measured in weeks, not a rebuild from scratch